Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 102, Issue 2, 2002, Pages 188-194

  Tanos, Vasilios ^a   Brzezinski, Amnon ^a   Drize, Olga ^a   Strauss, Nurith ^a   Peretz, Tamar ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Breast cancer; Breast cell cultures; Genistein; Mammary dysplasia; Tamoxifen treatment

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; TAMOXIFEN;

ARTICLE; BREAST CANCER; BREAST DYSPLASIA; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS POTENTIAL; PRIORITY JOURNAL;

EID: 0037052614     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(01)00582-6     Document Type: Article

References (39)

1. An overview of clinical cancer chemoprevention studies with emphasis on positive phase III studies
2. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multidrug resistance gene
3. Genistein inhibition of the growth of human breast cancer cells-independence from estrogen receptors and the multidrug resistance gene
4. Risk factors for breast cancer in women with proliferative breast disease
5. Phytoestrogen interaction with estrogen receptors in human breast cancer cells
6. Genistein, a specific inhibitor of tyrosine-specific protein kinases
7. Inhibitory effects of the kinase inhibitor genistein on mammalian DNA topoisomerase II
8. Inhibition of tyrosine protein kinase activity by synthetic isoflavones and flavones
9. The nuclear matrix from rat liver is capable of phosphorylating exogenous tyrosine-containing substance
10. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor
11. Cancer chemoprevention agent devepopment strategies for genistein
12. A review of the clinical effects of phytoestrogens
13. Inhibition of tumor metastasis by heparanase inhibiting species of heparin
14. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
15. Transformation of human breast epithelial cells by c-Ha-ras oncogene
16. Xenograft model of progressive human proliferative breast disease
17. Dual effect of normal and stimulated macrophages and their condition media, on target cell proliferation
18. Effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1
19. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro
20. Molecular effects of genistein on estrogen receptor mediated pathways
21. Case-control study of phytooestrogens and breast cancer
22. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
23. Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1
24. Antimutagens and anticarcinogens: a survey of putative interceptor molecules
25. Flavones 3. Synthesis, biological activities, and conformational analysis of isoflavone derivatives and related compounds
26. Genistein: a specific inhibitor of tyrosine-specific protein kinase
27. Effect of genistein on topoisomerase activity and on the growth of [val 12]Ha-ras-transformed NIH 3T3 cells
28. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity
29. Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein
30. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis
31. Phytoestrogen interaction with estrogen receptors in human breast cancer cells
32. In vitro hormonal effects of soybean isoflavones
33. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multidrug resistance gene
34. Effect of genistein on in vitro and in vivo models of cancer